Quantification of Gabapentin, Lacosamide, Perampanel, Pregabalin, Rufinamide, and Vigabatrin in Serum Using Liquid Chromatography-Tandem Mass Spectrometry
Authors:
- 1 December 2023
- book chapter
- Published by Springer Nature
- Vol. 2737, 25-32
Abstract
Antiepileptic drugs (AEDs) have been used to control epilepsy. More than 17 new AEDs, including gabapentin (GPN), lacosamide (LCM), perampanel (PER), pregabalin (PRG), rufinamide (RFM), and vigabatrin (VGB) have been approved and marketed since 1989. Accurate measurement of serum concentration of the antiepileptic drugs is crucial to achieve optimal efficacy and avoid adverse events. We describe an accurate and precise liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous quantification of GPN, LCM, PER, PRG, RFM, and VGB in serum. The method requires a small volume of sample (10 μL) and has a total chromatographic run time of 4 min for simultaneous measurement of these drugs. The method showed good accuracy with a bias of −0.2–5%. The intra- and inter-day imprecision were less than 5.0% for all the analytes. The linear assay ranges were 0.3–26 μg/mL for GPN, 0.15–24 μg/mL for LCM, 7.4–1881 ng/mL for PER, 0.03–13 μg/mL for PRG, 0.78–90 μg/mL for RFM, and 0.3–43 μg/mL for VGB. Key words Gabapentin Lacosamide Perampanel Pregabalin Rufinamide Vigabatrin Liquid chromatography-tandem mass spectrometry Antiepileptic drugs EpilepsyKeywords
This publication has 5 references indexed in Scilit:
- Epilepsy—Definition, Classification, Pathophysiology, and EpidemiologySeminars in Neurology, 2020
- Update on Antiepileptic Drugs 2019Continuum, 2019
- Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 UpdateTherapeutic Drug Monitoring, 2018
- Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017Pharmacopsychiatry, 2018
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008